Oualla, K., Castelo Branco, L., Nouiyakh, L., Amaadour, L., Benbrahim, Z., Arifi, S., & Mellas, N. (2021). Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker. Cancer Control.
Stile di citazione ChicagoOualla, Karima, Luis Castelo Branco, Lamiae Nouiyakh, Lamiae Amaadour, Zineb Benbrahim, Samia Arifi, e Nawfel Mellas. "Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 As a Biomarker." Cancer Control 2021.
Citazione MLAOualla, Karima, et al. "Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 As a Biomarker." Cancer Control 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.